PAN-KIR2DL NK-receptor antibodies and their use in diagnostik and therapy
Details for Australian Patent Application No. 2004253770 (hide)
International Classifications
Event Publications
12 January 2006 PCT application entered the National Phase
PCT publication WO2005/003172 Priority application(s): WO2005/003172
29 October 2009 Application Accepted
Published as AU-B-2004253770
24 December 2009 Application for Amendment
The nature of the amendment is as shown in the statement(s) filed 27 Nov 2009. Address for service in Australia - Davies Collison Cave Level 3 303 Coronation Drive Milton Business Centre QLD 4064
15 April 2010 Amendment Made
The nature of the amendment is as shown in the statement(s) filed 27 Nov 2009
22 April 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004253788-Flavonoid solubilization agent and method of solubilizing flavonoid
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser